Tower Research Capital LLC (Trc) Castle Biosciences Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.53 Billion
  • Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,791 shares of CSTL stock, worth $67,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,791
Previous 782 256.91%
Holding current value
$67,570
Previous $15,000 273.33%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$15.8 - $21.98 $31,742 - $44,157
2,009 Added 256.91%
2,791 $56,000
Q1 2025

May 15, 2025
SELL
$18.76 - $32.72 $196,661 - $343,003
-10,483 Reduced 93.06%
782 $15,000
Q4 2024

Feb 13, 2025
BUY
$26.52 - $34.67 $199,536 - $260,857
7,524 Added 201.12%
11,265 $300,000
Q3 2024

Nov 14, 2024
SELL
$17.4 - $31.47 $3,566 - $6,451
-205 Reduced 5.2%
3,741 $106,000
Q2 2024

Aug 13, 2024
BUY
$18.84 - $24.94 $70,763 - $93,674
3,756 Added 1976.84%
3,946 $85,000
Q1 2024

May 15, 2024
SELL
$18.06 - $25.3 $93,063 - $130,370
-5,153 Reduced 96.44%
190 $4,000
Q4 2023

Feb 13, 2024
BUY
$12.19 - $22.43 $53,221 - $97,929
4,366 Added 446.88%
5,343 $115,000
Q3 2023

Nov 14, 2023
SELL
$13.28 - $20.3 $132 - $203
-10 Reduced 1.01%
977 $16,000
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $4,220 - $9,412
362 Added 57.92%
987 $13,000
Q1 2023

May 09, 2023
BUY
$19.47 - $28.49 $3,115 - $4,558
160 Added 34.41%
625 $14,000
Q4 2022

Feb 10, 2023
SELL
$18.08 - $30.0 $24,516 - $40,680
-1,356 Reduced 74.46%
465 $11,000
Q3 2022

Nov 10, 2022
BUY
$22.51 - $34.32 $15,554 - $23,715
691 Added 61.15%
1,821 $47,000
Q2 2022

Aug 15, 2022
SELL
$16.0 - $45.99 $27,408 - $78,780
-1,713 Reduced 60.25%
1,130 $25,000
Q1 2022

May 12, 2022
BUY
$33.17 - $46.98 $79,608 - $112,751
2,400 Added 541.76%
2,843 $128,000
Q4 2021

Feb 14, 2022
SELL
$39.06 - $67.58 $87,338 - $151,108
-2,236 Reduced 83.46%
443 $19,000
Q3 2021

Nov 15, 2021
SELL
$60.13 - $77.6 $106,369 - $137,274
-1,769 Reduced 39.77%
2,679 $178,000
Q2 2021

Aug 16, 2021
BUY
$50.07 - $76.78 $30,342 - $46,528
606 Added 15.77%
4,448 $326,000
Q1 2021

May 17, 2021
SELL
$58.92 - $97.33 $295,542 - $488,207
-5,016 Reduced 56.63%
3,842 $263,000
Q4 2020

Feb 16, 2021
BUY
$43.6 - $73.05 $19,838 - $33,237
455 Added 5.41%
8,858 $595,000
Q3 2020

Nov 16, 2020
BUY
$38.47 - $52.03 $242,168 - $327,528
6,295 Added 298.62%
8,403 $432,000
Q2 2020

Aug 13, 2020
BUY
$27.28 - $43.01 $57,506 - $90,665
2,108 New
2,108 $79,000
Q1 2020

May 15, 2020
SELL
$23.08 - $35.53 $57,146 - $87,972
-2,476 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$15.74 - $35.04 $38,972 - $86,759
2,476 New
2,476 $85,000

Others Institutions Holding CSTL

# of Institutions
170
Shares Held
27.9M
Call Options Held
0
Put Options Held
0
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $637M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email